WO2002085847A3 - Glycine, n-[n-l-gamma-glutamyl-3-(nitrosothio)-l-valyl] and use thereof - Google Patents
Glycine, n-[n-l-gamma-glutamyl-3-(nitrosothio)-l-valyl] and use thereof Download PDFInfo
- Publication number
- WO2002085847A3 WO2002085847A3 PCT/EP2002/002598 EP0202598W WO02085847A3 WO 2002085847 A3 WO2002085847 A3 WO 2002085847A3 EP 0202598 W EP0202598 W EP 0202598W WO 02085847 A3 WO02085847 A3 WO 02085847A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nitrosothio
- valyl
- glutamyl
- glycine
- gamma
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002310939A AU2002310939A1 (en) | 2001-03-13 | 2002-03-08 | Glycine, n-(n-l-gamma-glutamyl-3-(nitrosothio)-l-valyl) and use thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES200100577A ES2173044B1 (en) | 2001-03-13 | 2001-03-13 | DERIVATIVES OF GLYCINE, N- (N-L-GAMMA-GLUTAMIL-3- (NITROSOTIO) -L-VALIL) AND ITS APPLICATIONS. |
ES200100577 | 2001-03-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002085847A2 WO2002085847A2 (en) | 2002-10-31 |
WO2002085847A3 true WO2002085847A3 (en) | 2003-10-30 |
Family
ID=8497059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/002598 WO2002085847A2 (en) | 2001-03-13 | 2002-03-08 | Glycine, n-[n-l-gamma-glutamyl-3-(nitrosothio)-l-valyl] and use thereof |
Country Status (5)
Country | Link |
---|---|
AU (1) | AU2002310939A1 (en) |
ES (1) | ES2173044B1 (en) |
PA (1) | PA8541201A1 (en) |
PE (1) | PE20021040A1 (en) |
WO (1) | WO2002085847A2 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0412699A2 (en) * | 1989-08-07 | 1991-02-13 | Takeda Chemical Industries, Ltd. | Nitrosothiol derivatives, their production and use |
WO2000044714A1 (en) * | 1999-01-27 | 2000-08-03 | Lacer, S.A. | S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
-
2001
- 2001-03-13 ES ES200100577A patent/ES2173044B1/en not_active Expired - Fee Related
-
2002
- 2002-03-08 AU AU2002310939A patent/AU2002310939A1/en not_active Abandoned
- 2002-03-08 WO PCT/EP2002/002598 patent/WO2002085847A2/en not_active Application Discontinuation
- 2002-03-11 PE PE2002000189A patent/PE20021040A1/en not_active Application Discontinuation
- 2002-03-12 PA PA20028541201A patent/PA8541201A1/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0412699A2 (en) * | 1989-08-07 | 1991-02-13 | Takeda Chemical Industries, Ltd. | Nitrosothiol derivatives, their production and use |
WO2000044714A1 (en) * | 1999-01-27 | 2000-08-03 | Lacer, S.A. | S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
EP1157987A1 (en) * | 1999-01-27 | 2001-11-28 | Lacer, S.A. | S-nitrosothiols as agents for the treatment of circulatory dysfunctions |
Non-Patent Citations (1)
Title |
---|
ASKEW S C ET AL: "Chemical mechanisms underlying the vasodilator and platelet anti-aggregating properties of S-nitroso-N-acetyl-DL-penicillamine and S-nitrosoglutathione.", BIOORGANIC & MEDICINAL CHEMISTRY. ENGLAND JAN 1995, vol. 3, no. 1, January 1995 (1995-01-01), pages 1 - 9, XP002225525, ISSN: 0968-0896 * |
Also Published As
Publication number | Publication date |
---|---|
PE20021040A1 (en) | 2002-11-19 |
WO2002085847A2 (en) | 2002-10-31 |
AU2002310939A1 (en) | 2002-11-05 |
ES2173044A1 (en) | 2002-10-01 |
ES2173044B1 (en) | 2004-01-16 |
PA8541201A1 (en) | 2003-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2427227A1 (en) | Lactam compound | |
HK1062677A1 (en) | 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
WO2001090091A8 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
MXPA04004837A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. | |
MXPA04004842A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. | |
IL161154A0 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
AU2003225617A1 (en) | Thiadiazolylpiperazine derivatives useful for treating or preventing pain | |
WO2005056524A3 (en) | Therapeutic agents useful for treating pain | |
WO2004037807A3 (en) | Medicinal arylethanolamine compounds | |
WO2006133941A3 (en) | Cannabinoid active pharmaceutical ingredient for improved dosage forms | |
WO2002042462A3 (en) | Therapeutic agents and methods of use thereof for treating an amyloidogenic disease | |
IL171977A (en) | Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same | |
WO2004029031A3 (en) | Therapeutic piperazine compounds | |
WO2005037798A3 (en) | Amide or thiomide derivatives and their use in the treatment of pain | |
WO2002088100A3 (en) | Deuterated 3-piperidinopropiophenone and medicaments containing said compounds | |
WO2005030753A3 (en) | Therapeutic agents useful for treating pain | |
PL1682528T3 (en) | BENZO [b][1,4] DIOXEPINE DERIVATIVES | |
RS44204A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
WO2002062322A3 (en) | Glycine betaine and its use as anti-hemorrhagic agent | |
AU2001246999A1 (en) | New neurokinin antagonists for use as medicaments | |
WO2002064552A8 (en) | 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES | |
RS44304A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
WO2000066550A8 (en) | New compounds | |
BE2016C017I2 (en) | ||
WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |